Tempus AI wins FDA clearance for ECG-MR tool to flag undiagnosed mitral regurgitation
Bitget2026/09/28 12:03- Tempus AI received FDA 510(k) clearance for ECG-MR, an AI tool that flags signs linked to undiagnosed moderate or severe mitral regurgitation.
- The software analyzes standard resting 12-lead ECGs to identify high-risk patients for follow-up evaluation such as diagnostic imaging.
- The clearance expands its ECG-AI portfolio to four FDA-cleared products spanning arrhythmia, heart function, pulmonary vascular, and valvular disease.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
JPMorgan raises AbbVie target price to $300
Netflix (NFLX.US) reportedly plans to lay off about 5% of its staff: The streaming giant faces growth pressure and trims its workforce ahead of earnings report.
According to reports, Netflix plans to lay off about 5% of its employees as early as next week.
Citi: Besent May "Slash" Long-term Bond Issuance Next Month, 20-year US Treasury Issuance Could Be Directly Canceled
Citi published a research report indicating that US Treasury Secretary Scott Besant is highly likely to reduce the issuance size of long-term US Treasury bonds, and may even completely cancel the issuance of 20-year Treasury bonds.
Rising energy prices intensify inflation concerns; US Treasury yields increase again, with the 10-year rising to 5.25%.
Persistently high energy prices have intensified market concerns about the inflation outlook and reinforced investor expectations of further interest rate hikes by the Federal Reserve. After experiencing significant volatility earlier this week, U.S. Treasury yields are edging back toward recent highs.
Crypto prices
More
